Bayesian models for cost-effectiveness analysis in the presence of structural zero costs

Bayesian modelling for cost-effectiveness data has received much attention in both the health economics and the statistical literature, in recent years. Cost-effectiveness data are characterised by a relatively complex structure of relationships linking a suitable measure of clinical benefit (e.g. quality-adjusted life years) and the associated costs. Simplifying assumptions, such as (bivariate) normality of the underlying distributions, are usually not granted, particularly for the cost variable, which is characterised by markedly skewed distributions. In addition, individual-level data sets are often characterised by the presence of structural zeros in the cost variable. Hurdle models can be used to account for the presence of excess zeros in a distribution and have been applied in the context of cost data. We extend their application to cost-effectiveness data, defining a full Bayesian specification, which consists of a model for the individual probability of null costs, a marginal model for the costs and a conditional model for the measure of effectiveness (given the observed costs). We presented the model using a working example to describe its main features. © 2013 The Authors. Statistics in Medicine published by John Wiley & Sons, Ltd.

[1]  D. Rubin,et al.  Inference from Iterative Simulation Using Multiple Sequences , 1992 .

[2]  C. Boshoff,et al.  First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial , 2012, The Lancet. Oncology.

[3]  G Baio,et al.  BCEA: A R Package to Perform Bayesian Cost-Effectiveness Analysis. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  D. Spiegelhalter,et al.  Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation , 2004 .

[5]  B O'Brien,et al.  Statistical analysis of cost effectiveness data. , 1999, The Journal of rheumatology.

[6]  M. G. Pittau,et al.  A weakly informative default prior distribution for logistic and other regression models , 2008, 0901.4011.

[7]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[8]  Gary K Grunwald,et al.  Analysis of repeated measures data with clumping at zero , 2002, Statistical methods in medical research.

[9]  Gianluca Baio,et al.  Bayesian Methods in Health Economics , 2012 .

[10]  S. Richardson,et al.  Strategy for modelling non-random missing data mechanisms in observational studies using Bayesian methods , 2010 .

[11]  Andrew Briggs,et al.  Statistical Analysis of Cost-Effectiveness Data , 2006 .

[12]  Simon G Thompson,et al.  How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  Nicola J Cooper,et al.  Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis. , 2007, Health economics.

[14]  M. A. Best.  Bayesian Approaches to Clinical Trials and Health‐Care Evaluation , 2005 .

[15]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[16]  Michael G. Kenward,et al.  Multiple Imputation and its Application , 2013 .

[17]  Reinaldo Boris Arellano-Valle,et al.  Mixed beta regression: A Bayesian perspective , 2012, Comput. Stat. Data Anal..

[18]  R. Grieve,et al.  Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care , 2004, BMJ : British Medical Journal.

[19]  A O'Hagan,et al.  Bayesian cost‐effectiveness analysis from clinical trial data , 2001, Statistics in medicine.

[20]  Anthony O'Hagan,et al.  Review of Statistical Methods for Analysing Healthcare Resources and Costs , 2010, Health economics.

[21]  Roderick J. A. Little,et al.  A Class of Pattern-Mixture Models for Normal Incomplete Data , 1994 .

[22]  S. Richardson,et al.  Strategy for Modelling Nonrandom Missing Data Mechanisms in Observational Studies Using Bayesian Methods , 2012 .

[23]  Simon G Thompson,et al.  Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. , 2005, Health economics.

[24]  P. Knekt,et al.  Confounding and missing data in cost-effectiveness analysis: comparing different methods , 2013, Health Economics Review.

[25]  Nicola J Cooper,et al.  Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach. , 2008, Health economics.

[26]  P. Palange,et al.  From the authors , 2007, European Respiratory Journal.

[27]  A. Briggs,et al.  Statistical Analysis of Cost-effectiveness Data: Willan/Statistical Analysis of Cost-effectiveness Data , 2006 .

[28]  Michael G. Kenward,et al.  Multiple Imputation and its Application: Carpenter/Multiple Imputation and its Application , 2013 .

[29]  Nicola J Cooper,et al.  Use of Bayesian Markov Chain Monte Carlo Methods to Model Cost-of-Illness Data , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  Martyn Plummer,et al.  JAGS: Just Another Gibbs Sampler , 2012 .

[31]  G. Baio.  Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  Karl Claxton,et al.  A Framework for Addressing Structural Uncertainty in Decision Models , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  N M Laird,et al.  Missing data in longitudinal studies. , 1988, Statistics in medicine.

[34]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[35]  R. Little.  Pattern-Mixture Models for Multivariate Incomplete Data , 1993 .